By now everybody knows the gist of the Theranos story: A high-flying blood testing startup led by a captivating CEO crashes to earth after revelations that its technology doesn’t work. The dogged reporting efforts by Wall Street Journal journalist John Carreyrou were instrumental in exposing a corporate fraud that many otherwise powerful and brainy people bought into.

Carreyrou’s new book about the Theranos saga, “Bad Blood,” offers a deeper look at what happened at the company and how it managed to achieve stunning sleights of hand. But as much as it’s a story about science and corporate intrigue, it’s also a tale about lawyers. And it doesn’t make Theranos’ long-serving counsel, David Boies and his firm, look all that great.